sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Companion Diagnostic Technologies Market Scope And Analysis

  • Report Code : TIPRE00004732
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Companion Diagnostic Technologies Market Scope and Analysis Report by 2031

Buy Now

Companion Diagnostic Technologies Market Report Companion Diagnostic Technologies Market Size and Share Companion Diagnostic Technologies Market Scope and Analysis

Companion Diagnostic Technologies Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Technology
  • PCR
  • IHC
  • NGS
  • ISH
By Indication
  • Breast cancer
  • NSCLC
  • Colorectal Cancer
  • Neurological Disorders
  • Infectious Diseases
By End User
  • Pharmaceutical and Biopharmaceutical Companies
  • Reference Lab
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BioSpace
  • QIAGEN
  • F Hoffmann La Roche Ltd
  • Abbott
  • bioMerieux SA
  • Myriad Genetics Inc
  • BioGenex
  • Thermo Fisher Scientific Inc
  • Leica Biosystems Nussloch GmbH